Immuron Limited - ADR

-0.08 (-4.26%)
7:30:47 PM EDT: $1.93 +0.02 (+1.05%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Immuron Limited - ADR Stock, NASDAQ:IMRN

62 Lygon Street, Level 3, Carlton, Victoria (VIC) 3053
Phone: +61.3.9824.5254
Number of Employees:


Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum. This technology can be used to target viruses or bacteria and neutralize the toxins they produce at mucosal surfaces. It operates through the Research and Development, and Hyperimmune Products segments. The Research and Development segment includes projects performed in Australia and United States. The Hyperimmune Products segment is composed of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994 and is headquartered in Carlton, Australia.